Nutritional products that eliminate the feeling of hunger are in “high demand”: OptiBiotix Founder
We delve into life science, the microbiome, self-care and integrative medicine in Latin America with Stephen O’Hara, CEO, OptiBiotix.
OptiBiotix Health subsidiary inks UK probiotics distribution deal
©Optibiotix Health
ProBiotix Health, a subsidiary of UK microbiome firm OptiBiotix Health announces a distribution deal with Cambridge Commodities (CCL) for its LPLDL ingredient and the dietary supplement CholBiomex3.
Related news
OptiBiotix reinforce CholBiome stamp in Eastern Europe with Velinoff Pharma deal
OptiBiotix Health’s Eastern European interest gains further tract as the firm is to leverage an existing deal with Bulgarian company Velinoff Pharma to increase market exposure to its probiotic CholBiome.
Kappa Bioscience’s vitamin K combines with Optibiotix probiotic in vascular health deal
OptiBiotix subsidiary ProBiotix signs a license agreement with Kappa Bioscience for the use of its Lactobacillus plantarum (LPLDL) probiotic strain to address cardiovascular health.